CBO projects that healthcare costs will account for nearly half of the U.S. economy by 2082, with only about 10 percent of that increase caused by an aging population. In a first-of-its kind report on the long-term costs of health care, CBO said Medicare and Medicaid would be 19 percent of the gross domestic product, or 38 percent of total healthcare spending. CBO Director Orszag said at a morning briefing that the bulk of the projected increase in healthcare spending can be attributed to factors that do not necessarily lead to better health outcomes, such as the "open-ended adoption of new technologies that may be not that valuable."

By Fawn Johnson

The National Patient Advocate Foundation recently issued a statement regarding the new Food and Drug Administration (FDA) label on erythropoietin stimulating agents (ESAs).  NPAF commends the FDA and ESA sponsors for their diligence to gather the information patients and physicians need to make well-informed decisions about the use of these important therapies.  NPAF believes that both the sponsors and the FDA have the responsibility to demonstrate to the American public that ESA drugs are safe and effective when administered within the recommended guidelines.

View Press Release

On November 8th, the Food and Drug Administration (FDA) announced labeling changes for erythropoiesis-stimulating agents (ESAs) addressing the potential risk that the drugs Aranesp and Procrit/Epogen pose to patients with cancer and patients with chronic kidney failure.  National Patient Advocate Foundation participated in the FDA briefing and due to the complexity of the issue, feels patients will benefit by having all FDA materials available to them so that they may discuss treatment issues with their physicians.

The Senate approved a revised SCHIP bill on November 1st by a vote of 64-30.  The legislation resembles the $35 billion expansion that President Bush vetoed last month that would cover 10 million children.  After failing to override the President's veto, Congress revised the legislation and limited coverage to children in families with annual incomes below 300% of the federal poverty level.  Another extension in funding is expected since current funding for SCHIP runs out November 16th.